2021
DOI: 10.1093/cid/ciab147
|View full text |Cite
|
Sign up to set email alerts
|

Plasma Metabolomic Profiling of Patients Recovered From Coronavirus Disease 2019 (COVID-19) With Pulmonary Sequelae 3 Months After Discharge

Abstract: Background Elucidation of the molecular mechanisms involved in the pathogenesis of coronavirus disease (COVID-19) may help to discover therapeutic targets. Methods To determine the metabolomic profile of circulating plasma from COVID-19 survivors with pulmonary sequelae 3 months after discharge, a random, outcome-stratified case-control sample was analyzed. We enrolled 103 recovered COVID-19 patients as well as 27 healthy don… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
37
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 45 publications
(39 citation statements)
references
References 41 publications
2
37
0
Order By: Relevance
“… 54 Moreover, taurine depletion can lead to pancreatic β-cell malfunction, which may reduce plasma insulin levels. 55 In our study, taurine was reduced in the recovered COVID-19 patients, which has also been validated in our another cohort study (another five representative metabolites [arginine, indoleacetic acid, uric acid, pyroglutamic acid and PE 40:8] also have been validated) 20 ( Supplementary Figure 2 ). The relationship between taurine and α-HBDH was reversed from a positive correlation in the HCs to a negative one in the RMs ( Figure 6D ), indicating that the cardiovascular function might be affected by the abnormally reduced taurine in recovered COVID-19 patients.…”
Section: Discussionsupporting
confidence: 81%
See 1 more Smart Citation
“… 54 Moreover, taurine depletion can lead to pancreatic β-cell malfunction, which may reduce plasma insulin levels. 55 In our study, taurine was reduced in the recovered COVID-19 patients, which has also been validated in our another cohort study (another five representative metabolites [arginine, indoleacetic acid, uric acid, pyroglutamic acid and PE 40:8] also have been validated) 20 ( Supplementary Figure 2 ). The relationship between taurine and α-HBDH was reversed from a positive correlation in the HCs to a negative one in the RMs ( Figure 6D ), indicating that the cardiovascular function might be affected by the abnormally reduced taurine in recovered COVID-19 patients.…”
Section: Discussionsupporting
confidence: 81%
“… 18 , 19 In addition, we recently found that discharged patients with pulmonary sequelae also had disordered plasma metabolite profiles. 20 Therefore, understanding the metabolomic changes of discharged COVID-19 patients who lack a previous underlying disease after several months of recovery may help us find clues to the physiological and pathophysiological processes during recovery and better manage these patients.…”
Section: Introductionmentioning
confidence: 99%
“…Emerging evidence suggests that COVID-19 survivors have impaired lung function, with the development of pulmonary fibrosis(2, 14). Tissue-resident CD8 + T cells drive age-associated chronic lung sequelae after viral pneumonia(45).…”
Section: Discussionmentioning
confidence: 99%
“…Our findings are in line with published papers(42)(43)(44).SARS-CoV-2 infection may induce a cytotoxic response, characterized by simultaneous production of GZMB and perforin in T cells, NK cells and γδ T cells inPPSs. Excessive activation of cytotoxic T, NK and γδ T cells is not protective but rather drives pulmonary damage after SARS-CoV-2 infection.Emerging evidence suggests that COVID-19 survivors have impaired lung function, with the development of pulmonary fibrosis(2,14). Tissue-resident CD8 + T cells drive age-associated chronic lung sequelae after viral pneumonia(45).Besides, clonally expanded tissue-resident memory-like Th17 cells may interact with pro-fibrotic macrophages and cytotoxic CD8+ T cells leading to the formation of pulmonary fibrosis(4).…”
mentioning
confidence: 99%
“…A number of analytical methods for mass spectrometry in clinical laboratories were developed during the recent past, and the development gains additional momentum as the CoVID-19 pandemics holds the mankind in grip and methods for fast HPLC-MS have been developed and applied [6][7][8][9][10][11][12][13][14][15].…”
Section: Separation Approachesmentioning
confidence: 99%